PERSPECTIVES OF APPLICATION OF ANTIBODIES AGAINST ENDOGLIN (CD105) FOR VISUALIZATION AND ANTI-ANGIOGENE THERAPY OF TUMORS. Voprosy onkologii, v. 64, n. 4, p. 504–507, 1 Apr.2018.